🇺🇸 FDA
Pipeline program

DCC-3014, DCC-3014, Placebo to match DCC-3014

DCC-3014-03-001

Phase 3 small_molecule active

Quick answer

DCC-3014, DCC-3014, Placebo to match DCC-3014 for Tenosynovial Giant Cell Tumor is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Tenosynovial Giant Cell Tumor
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials